IMP dehydrogenase (IMPDH) catalyzes the oxidation of IMP to XMP with conver
sion of NAD(+) to NADH. This reaction is the rate-limiting step in de novo
guanine nucleotide biosynthesis. IMPDH is a target for antitumor, antiviral
, and immunosuppressive chemotherapy. We have determined the complete kinet
ic mechanism for IMPDH from Tritrichomonas foetus using ligand binding, iso
tope effect, presteady-state kinetic, and rapid quench kinetic experiments.
Both substrates bind to the free enzyme, which suggests a random mechanism
. LMP binds to the enzyme in two steps. Two steps are also involved when IM
P binds to a mutant IMPDH in which the active site Cys is substituted with
a Ser. This observation suggests that this second step may be a conformatio
nal change of the enzyme. No V-m isotope effect is observed when [2-H-2]NP
is the substrate which indicates that hydride transfer is not rate-limiting
. This result is confirmed by the observation of a pre-steady-state burst o
f NADH production when monitored by absorbance. However, when NADH producti
on was monitored by fluorescence, the rate constant for the exponential pha
se is 5-10-fold lower than when measured by absorbance. This observation su
ggests that the fluorescence of enzyme-bound NADH is quenched and that this
transient represents NADH release from the enzyme. The time-dependent form
ation and decay of [C-14]E-XMP* intermediates was monitored using rapid que
nch kinetics. These experiments indicate that both NADH release and E-XMP*
hydrolysis are rate-limiting and suggest that NADH release precedes hydroly
sis of E-XMP*.